Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 554INDUSTRY 227NIH 70NETWORK 17OTHER_GOV 12INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 71Genitourinary 59Thoracic 29Breast 14Lymphoid 12Other hematologic neoplasm 9Gynecologic 8Tumor-Agnostic 7Head & Neck 7Dermatologic 7CNS 4Other 3Plasma cell 2Myeloid 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Fanconi Anemia, Complementation Group N 1Fanconi Anemia, Complementation Group D1 1

Interventions

olaparib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Interventional × Classical hematology × Clear all
NCT04038502 2025-08-20

COBRA

VA Office of Research and Development

Phase 2 Recruiting
100 enrolled
Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡